US 7511137
Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates
granted A61PA61P35/00A61P43/00
Quick answer
US patent 7511137 (Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates) held by Rigel Pharmaceuticals, Inc. expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P35/00, A61P43/00